国邦医药 (605507.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(国邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 4,053,476,803.522,809,720,242.621,410,162,706.265,720,924,721.914,113,348,595.702,703,468,710.181,176,098,332.11
 营业利润(元) 563,975,837.46417,515,967.87230,550,561.321,052,877,800.44840,332,164.25578,619,627.29239,587,107.48
 利润总额(元) 559,550,561.80412,906,121.21228,633,029.611,035,639,362.90830,436,121.65568,135,374.44235,103,308.71
 净利润(元) 487,655,739.51356,856,363.05194,971,355.47920,622,062.87721,356,274.77494,995,032.30200,306,762.89
 归属于母公司股东的净利润(元) 489,073,265.39357,470,775.26194,629,337.80920,904,230.12721,064,644.06495,038,347.85200,394,843.05
盈利能力:
 销售毛利率(%) 24.6524.6426.6127.5528.3829.6031.07
 销售净利率(%) 12.0312.7013.8316.0917.5418.3117.03
 净资产收益率(%) 6.865.142.80----
 总资产报酬率ROA(%) 5.554.112.59----
 投入资本回报率ROIC(%) 5.624.152.2412.049.586.712.87
营运能力:
 存货周转率(次) 2.221.470.72----
 应收账款周转率(次) 6.474.312.26----
 总资产周转率(次) 0.440.310.16----
偿债能力:
 资产负债率(%) 25.2825.6424.8420.8820.6020.4915.64
 股东权益比率(%) 74.7474.3775.1679.1279.4079.5184.37
 已获利息倍数(倍) -11.46-9.19-144.20-14.23-11.29-19.55283.81
 流动比率 2.492.492.372.752.902.993.87
 速动比率 1.621.641.681.972.001.872.40
发展能力:
 营业收入增长率(%) -1.463.9319.9026.9828.0120.562.96
 营业利润增长率(%) -32.89-27.84-3.7730.1840.7431.578.30
 税后利润增长率(%) -32.17-27.79-2.8830.4338.3831.078.26
 净资产增长率(%) 5.086.6612.2712.757.9984.2489.21
 总资产增长率(%) 11.6414.0326.0220.3713.6155.7740.45

前瞻产业研究院